Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenSCs Infusion in Type 1 Diabetes
NCT01496339Phase 2Unknown
- Sponsor
- S-Evans Biosciences
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of menstrual blood-derived mesenchymal stem cells in type 1 diabetes mellitus (T1D), sponsored by S-Evans Biosciences. Status: unknown.
02
Drugs
menstrual blood-derived mesenchymal stem cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01496339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01496339.